Micro-Elimination of Hepatitis C Among Patients with Kidney Disease by Using Electronic Reminder System-A Hospital-Based Experience

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Jan 21

PMID 35054120

Authors

Pei-Yuan Su

Wei-Wen Su

Yu-Chun Hsu

Shu-Yi Wang

Ping-Fang Chiu

Hsu-Heng Yen

Affiliations

Soon will be listed here.

Abstract

Background: Little is known about the use of an electronic reminder system for HCV screening among patients with kidney disease. In this study, we tried to determine whether reminder systems could improve the HCV screening rate in patients with kidney disease.

Methods: Patients with kidney disease were enrolled from August 2019 to December 2020 to automatically screen and order HCV antibody and RNA testing in outpatient departments.

Results: A total of 19,316 outpatients with kidney disease were included, and the mean age was 66.5 years. The assessment rate of HCV antibody increased from 53.1% prior to the reminder system to 79.8% after the reminder system ( < 0.001), and the assessment rate of HCV RNA increased from 71% to 82.9%. The anti-HCV seropositivity rate decreased from 7.3% at baseline to 2.5% after the implementation of the reminder system ( < 0.001), and the percentage of patients with detectable HCV RNA among those with anti-HCV seropositivity decreased from 69.1% at baseline to 46.8% ( < 0.001).

Conclusions: The feasibility of an electronic reminder system for HCV screening among patients with kidney disease in a hospital-based setting was demonstrated.

Citing Articles

Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis.

Yen H, Chen Y, Lai J, Chen H, Yao C, Huang S J Clin Med. 2022; 11(7).

PMID: 35407462 PMC: 8999637. DOI: 10.3390/jcm11071853.

References

Sidlow R, Msaouel P . Improving Hepatitis C Virus Screening Rates in Primary Care: A Targeted Intervention Using the Electronic Health Record. J Healthc Qual. 2015; 37(5):319-23. DOI: 10.1097/JHQ.0000000000000010. View

Wei Y, Hsu P, Jia-Jung Lee , Niu S, Huang J, Hsu C . Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group. J Viral Hepat. 2021; 28(5):719-727. DOI: 10.1111/jvh.13477. View

Konerman M, Thomson M, Gray K, Moore M, Choxi H, Seif E . Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers. Hepatology. 2017; 66(6):1805-1813. PMC: 5696058. DOI: 10.1002/hep.29362. View

Yoshioka N, Okumura A, Yamamoto Y, Yamaguchi K, Kaga A, Yamada K . Promoting notification and linkage of HBs antigen and anti-HCV antibody-positive patients through hospital alert system. BMC Infect Dis. 2017; 17(1):330. PMC: 5422930. DOI: 10.1186/s12879-017-2438-1. View

Yen H, Su P, Liu I, Zeng Y, Huang S, Hsu Y . Direct-acting antiviral treatment for Hepatitis C Virus in geriatric patients: a real-world retrospective comparison between early and late elderly patients. PeerJ. 2021; 9:e10944. PMC: 7977377. DOI: 10.7717/peerj.10944. View

Yen H, Su P, Zeng Y, Liu I, Huang S, Hsu Y . Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting. PLoS One. 2020; 15(8):e0237582. PMC: 7425913. DOI: 10.1371/journal.pone.0237582. View

Huang C, Wu P, Yeh M, Huang C, Liang P, Hsu C . Scaling up the in-hospital hepatitis C virus care cascade in Taiwan. Clin Mol Hepatol. 2020; 27(1):136-143. PMC: 7820217. DOI: 10.3350/cmh.2020.0150. View

MacLean C, Berger C, Cangiano M, Ziegelman D, Lidofsky S . Impact of electronic reminder systems on hepatitis C screening in primary care. J Viral Hepat. 2018; 25(8):939-944. DOI: 10.1111/jvh.12885. View

Wu G, Yang W, Liu C, Pwu R, Chien R, Lee P . The epidemiological profile of chronic hepatitis C with advanced hepatic fibrosis regarding virus genotype in Taiwan: A nationwide study. J Formos Med Assoc. 2021; 120(7):1444-1451. DOI: 10.1016/j.jfma.2021.01.005. View

10.

Pol S, Parlati L, Jadoul M . Hepatitis C virus and the kidney. Nat Rev Nephrol. 2018; 15(2):73-86. DOI: 10.1038/s41581-018-0081-8. View

11.

Chen Y, Chen C, Chen J, Hsu N, Wei S, Hou S . Secular Trends and Geographic Maps of Hepatitis C Virus Infection among 4 Million Blood Donors in Taiwan from 1999 to 2017. Hepatol Commun. 2020; 4(8):1193-1205. PMC: 7395065. DOI: 10.1002/hep4.1531. View

12.

Liu L, Xu H, Hu Y, Shang J, Jiang J, Yu L . Hepatitis C screening in hospitals: find the missing patients. Virol J. 2019; 16(1):47. PMC: 6469068. DOI: 10.1186/s12985-019-1157-1. View

13.

Khan M, Mahmoud M, Butt A . Hepatitis c virus and chronic kidney disease. Expert Rev Gastroenterol Hepatol. 2020; 14(7):579-590. DOI: 10.1080/17474124.2020.1776111. View

14.

Castrejon M, Chew K, Javanbakht M, Humphries R, Saab S, Klausner J . Implementation of a Large System-Wide Hepatitis C Virus Screening and Linkage to Care Program for Baby Boomers. Open Forum Infect Dis. 2017; 4(3):ofx109. PMC: 5527269. DOI: 10.1093/ofid/ofx109. View

15.

Negro F, Forton D, Craxi A, Sulkowski M, Feld J, Manns M . Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology. 2015; 149(6):1345-60. DOI: 10.1053/j.gastro.2015.08.035. View

16.

Morales-Arraez D, Alonso-Larruga A, Diaz-Flores F, Garcia Dopico J, de Vera A, Quintero E . Predictive factors for not undergoing RNA testing in patients found to have hepatitis C serology and impact of an automatic alert. J Viral Hepat. 2019; 26(9):1117-1123. DOI: 10.1111/jvh.13122. View

17.

Morales-Arraez D, Hernandez-Guerra M . Electronic Alerts as a Simple Method for Amplifying the Yield of Hepatitis C Virus Infection Screening and Diagnosis. Am J Gastroenterol. 2019; 115(1):9-12. DOI: 10.14309/ajg.0000000000000487. View

18.

Hu T, Su W, Yang C, Yang C, Kuo W, Chen Y . Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan. Am J Kidney Dis. 2021; 78(4):511-519.e1. DOI: 10.1053/j.ajkd.2021.03.017. View

19.

Federman A, Kil N, Kannry J, Andreopolous E, Toribio W, Lyons J . An Electronic Health Record-based Intervention to Promote Hepatitis C Virus Testing Among Adults Born Between 1945 and 1965: A Cluster-randomized Trial. Med Care. 2017; 55(6):590-597. PMC: 5759753. DOI: 10.1097/MLR.0000000000000715. View

20.

Seo Y, Jung E, Kim J, Jung Y, Kim J, An H . Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia. Korean J Intern Med. 2009; 24(4):302-8. PMC: 2784972. DOI: 10.3904/kjim.2009.24.4.302. View